PT Kalbe Farma Tbk PTKFF Stock
PT Kalbe Farma Tbk Price Chart
PT Kalbe Farma Tbk PTKFF Financial and Trading Overview
PT Kalbe Farma Tbk stock price | 0.08 USD |
Previous Close | 0.14 USD |
Open | 0.14 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.14 - 0.14 USD |
52 Week Range | 0.11 - 0.17 USD |
Volume | 300 USD |
Avg. Volume | 47 USD |
Market Cap | 6.39B USD |
Beta (5Y Monthly) | 0.273287 |
PE Ratio (TTM) | Infinity |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | 0 (1.83%) |
Ex-Dividend Date | May 12, 2023 |
1y Target Est | N/A |
PTKFF Valuation Measures
Enterprise Value | 6.4B USD |
Trailing P/E | Infinity |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
PT Kalbe Farma Tbk Stock Price History
Beta (5Y Monthly) | 0.273287 |
52-Week Change | 31.02% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.17 USD |
52 Week Low | 0.11 USD |
50-Day Moving Average | 0.14 USD |
200-Day Moving Average | 0.13 USD |
PTKFF Share Statistics
Avg. Volume (3 month) | 47 USD |
Avg. Daily Volume (10-Days) | 70 USD |
Shares Outstanding | 46.26B |
Float | 18.96B |
Short Ratio | N/A |
% Held by Insiders | 58.28% |
% Held by Institutions | 15.08% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.47779998 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 11.42% |
Operating Margin (ttm) | 0% |
Gross Margin | 39.52% |
EBITDA Margin | 16.70% |
Management Effectiveness
Return on Assets (ttm) | 9.78% |
Return on Equity (ttm) | 15.38% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | 12.19% |
Gross Profit (ttm) | 11.52T USD |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | 2.50% |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | 3.88 USD |
Current Ratio (mrq) | 3.81 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of PT Kalbe Farma Tbk
Country | United States |
State | N/A |
City | Jakarta |
Address | Gedung KALBE |
ZIP | 10510 |
Phone | 62 21 4287 3888 |
Website | https://www.kalbe.co.id |
Industry | Drug Manufacturers-General |
Sector(s) | Healthcare |
Full Time Employees | 13288 |
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. It offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals, pharmacies, and drug stores. The company also provides over-the-counter drugs; energy drinks, ready-to-drink products, supplements, and other preventive products; and nutritional products for infants, toddlers, children, teenagers, adults, pregnant and lactating women, and elders, as well as for consumers with special medical needs. In addition, it offers contract services, including clinical study management, bioavailability/bioequivalence studies, and contract analysis to pharmaceutical companies; and animal health products, as well as operates Mitrasana Clinics, a health care service. Further, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.
Q&A For PT Kalbe Farma Tbk Stock
What is a current PTKFF stock price?
PT Kalbe Farma Tbk PTKFF stock price today per share is 0.08 USD.
How to purchase PT Kalbe Farma Tbk stock?
You can buy PTKFF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PT Kalbe Farma Tbk?
The stock symbol or ticker of PT Kalbe Farma Tbk is PTKFF.
Which industry does the PT Kalbe Farma Tbk company belong to?
The PT Kalbe Farma Tbk industry is Drug Manufacturers-General.
How many shares does PT Kalbe Farma Tbk have in circulation?
The max supply of PT Kalbe Farma Tbk shares is 45.95B.
What is PT Kalbe Farma Tbk Price to Earnings Ratio (PE Ratio)?
PT Kalbe Farma Tbk PE Ratio is now.
What was PT Kalbe Farma Tbk earnings per share over the trailing 12 months (TTM)?
PT Kalbe Farma Tbk EPS is 0 USD over the trailing 12 months.
Which sector does the PT Kalbe Farma Tbk company belong to?
The PT Kalbe Farma Tbk sector is Healthcare.